Literature DB >> 34711370

Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective.

Kimberley Hubens1, Marieke Krol2, Joanna Coast3, Michael F Drummond4, Werner B F Brouwer5, Carin A Uyl-de Groot6, Leona Hakkaart-van Roijen5.   

Abstract

OBJECTIVES: This study aimed (1) to perform a systematic literature review of instruments for measuring productivity loss of paid and unpaid work and (2) to assess the suitability (in terms of identification, measurement, and valuation) of these instruments for use in health economic evaluations from a societal perspective.
METHODS: Articles published from 2018 were sourced from PubMed/Medline, PsycInfo, Embase, and Econlit. Using 2 separate search strategies, eligible economic evaluations and validation studies were selected and unique measurement instruments identified. A data-extraction form was developed by studying previous literature and consulting an international panel of experts in the field of productivity costs. This data-extraction form was applied to assess the suitability of instruments for use in economic evaluations.
RESULTS: A total of 5982 articles were retrieved from the databases, of which 99 economic evaluations and 9 validation studies were included in the review. A total of 42 unique measurement instruments were identified. Nine instruments provided quantified measures of absenteeism, presenteeism, and unpaid work. Five instruments supplied the necessary information to enable the use of at least 1 common valuation method. The Health and Labour Questionnaire-Short Form, Health and Labour Questionnaire, and Institute for Medical Technology Assessment Productivity Cost Questionnaire met both criteria. Nevertheless, the developers replaced the Health and Labour Questionnaire-Short Form and Health and Labour Questionnaire by the more recently developed Institute for Medical Technology Assessment Productivity Cost Questionnaire.
CONCLUSIONS: Although many instruments for measuring productivity loss were identified, most were not suitable for capturing productivity changes for economic evaluations from a societal perspective. Future research can benefit from this study by making an informed instrument choice for the measurement of productivity loss of paid and unpaid work.
Copyright © 2021 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  economic evaluation; indirect costs; measurement; measurement instruments; productivity costs; productivity loss; questionnaire; survey; systematic review

Mesh:

Year:  2021        PMID: 34711370     DOI: 10.1016/j.jval.2021.05.002

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  6 in total

1.  Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?

Authors:  Ashley A Leech; Pei-Jung Lin; Brittany D'Cruz; Susan K Parsons; Tara A Lavelle
Journal:  Appl Health Econ Health Policy       Date:  2022-08-23       Impact factor: 3.686

2.  A Comparison of the Validities of Traditional Chinese Versions of the Work Productivity and Activity Impairment Questionnaire: General Health and the World Health Organization's Health and Work Performance Questionnaire.

Authors:  Kim-Ngan Ta-Thi; Kai-Jen Chuang
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

3.  The Impact of Hypoglycemia on Productivity Loss and Utility in Patients With Type 2 Diabetes Treated With Insulin in Real-world Canadian Practice: Protocol for a Prospective Study.

Authors:  Veronique Lambert-Obry; Jean-Philippe Lafrance; Michelle Savoie; Jean Lachaine
Journal:  JMIR Res Protoc       Date:  2022-03-28

Review 4.  Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China.

Authors:  Shan Jiang; Yitong Wang; Lei Si; Xiao Zang; Yuan-Yuan Gu; Yawen Jiang; Gordon G Liu; Jing Wu
Journal:  BMJ Glob Health       Date:  2022-08

5.  Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®).

Authors:  Suzete Costa; José Guerreiro; Inês Teixeira; Dennis K Helling; João Pereira; Céu Mateus
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

6.  Health care system and patient costs associated with receipt of minimally adequate treatment for depression and anxiety disorders in older adults.

Authors:  Catherine Lamoureux-Lamarche; Djamal Berbiche; Helen-Maria Vasiliadis
Journal:  BMC Psychiatry       Date:  2022-03-10       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.